Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PROKthis companyProKidney Corp.	$1.16	-4.31×	-0.3×	335.98×	-3.99×	-22.6%	100.0%	-18477.8%	-7725.2%	6.8%	-53.9%	-45.1%	-0×	0.72×	-41,251.75×	9.13×	0.0%	1	-0.18	2	C
ARDXArdelyx, Inc.	$2.95	-22.42×	8.42×	3.45×	-53.09×	-5941.7%	89.5%	-10.1%	-15.1%	-36.9%	-9.9%	-3.1%	1.27×	-4.92×	-1.44×	4.31×	0.0%	2	-0.11	1	D+
DMACDiaMedica Therapeutics Inc.	$9.81	-11.37×	6.66×	0×	-10.97×	-96.7%	0.0%	0.0%	0.0%	-58.4%	-61.0%	-7.8%	0×	0.47×	0×	11.81×	0.0%	1	37.36	2	C
MAZEMaze Therapeutics, Inc.	$34.47	-13.58×	5.02×	0×	-12.54×	-87.4%	0.0%	0.0%	0.0%	-36.9%	-37.7%	-6.3%	0.07×	1.29×	0×	15.5×	0.0%	3	11.54	2	C
TVTXTravere Therapeutics, Inc.	$50.47	-68.23×	29.69×	6.95×	164.03×	-591.5%	97.9%	-12.8%	-5.2%	-22.2%	-13.9%	-0.6%	2.86×	10.61×	-5.85×	2.74×	0.0%	4	1.52	1	D+
UNCYUnicycive Therapeutics, Inc.	$3.69	-3.46×	3.04×	0×	-2.42×	-48.2%	0.0%	0.0%	0.0%	-87.9%	-97.1%	-34.2%	0.01×	1.12×	-415.73×	2.59×	0.0%	2	-0.44	2	C+
Peer median	—	-13.58×	6.66×	0×	-10.97×	-96.7%	0.0%	0.0%	0.0%	-36.9%	-37.7%	-6.3%	0.07×	1.12×	-1.44×	4.31×	0.0%	2	1.52	2	—